Haemonetics Corporation
Hedge Funds Holdings
Last updated:
Haemonetics Corporation‘s stocks are currently a part of 241 hedge funds’ portfolios, which represents 86.36% of the total amount of its stocks outstanding. This makes up a total of 44.63M shares of Haemonetics Corporation. Compared to the previous quarter, the number fell by -13.67% or -7.06M shares fewer. As for the holding position changes, 32.37% (78) of current hedge fund investors increased the number of shares held, 36.93% (89) of current holders sold a part of the shares held, and 7.88% (19) closed the holdings completely. 46 hedge funds are new holders of Haemonetics Corporation stock in Q3 2022, it is 19.09% of total holders.
Hedge funds holding Haemonetics (Q4 2017 – Q3 2022)
| Q4 2017 | 243 |
|---|---|
| Q1 2018 | 259 |
| Q2 2018 | 290 |
| Q3 2018 | 290 |
| Q4 2018 | 278 |
| Q1 2019 | 260 |
| Q2 2019 | 254 |
| Q3 2019 | 272 |
| Q4 2019 | 294 |
| Q1 2020 | 267 |
| Q2 2020 | 279 |
| Q3 2020 | 261 |
| Q4 2020 | 280 |
| Q1 2021 | 292 |
| Q2 2021 | 254 |
| Q3 2021 | 243 |
| Q4 2021 | 251 |
| Q1 2022 | 231 |
| Q2 2022 | 239 |
| Q3 2022 | 241 |
Hedge funds changes in Haemonetics positions (Q4 2017 – Q3 2022)
| Q4 2017 | 57 | 75 | 87 | 19 | 5 |
|---|---|---|---|---|---|
| Q1 2018 | 47 | 83 | 100 | 24 | 5 |
| Q2 2018 | 67 | 90 | 103 | 34 | -4 |
| Q3 2018 | 52 | 71 | 143 | 48 | -24 |
| Q4 2018 | 43 | 96 | 99 | 55 | -15 |
| Q1 2019 | 39 | 94 | 97 | 55 | -25 |
| Q2 2019 | 48 | 71 | 103 | 50 | -18 |
| Q3 2019 | 43 | 90 | 97 | 25 | 17 |
| Q4 2019 | 52 | 101 | 104 | 24 | 13 |
| Q1 2020 | 43 | 84 | 104 | 67 | -31 |
| Q2 2020 | 57 | 104 | 94 | 43 | -19 |
| Q3 2020 | 39 | 85 | 105 | 55 | -23 |
| Q4 2020 | 54 | 74 | 114 | 34 | 4 |
| Q1 2021 | 52 | 98 | 105 | 37 | 0 |
| Q2 2021 | 52 | 102 | 78 | 86 | -64 |
| Q3 2021 | 31 | 90 | 93 | 41 | -12 |
| Q4 2021 | 51 | 89 | 80 | 40 | -9 |
| Q1 2022 | 27 | 93 | 81 | 45 | -15 |
| Q2 2022 | 37 | 80 | 88 | 24 | 10 |
| Q3 2022 | 46 | 78 | 89 | 19 | 9 |
Hedge funds changes in Haemonetics stock options (Q4 2017 – Q3 2022)
| Q4 2017 | 889,000 | 1,400,000 |
|---|---|---|
| Q1 2018 | 1,046,000 | 0 |
| Q2 2018 | 1,228,000 | 15,291,000 |
| Q3 2018 | 3,425,000 | 4,354,000 |
| Q4 2018 | 810,000 | 2,291,000 |
| Q1 2019 | 3,551,000 | 962,000 |
| Q2 2019 | 1,071,000 | 2,130,000 |
| Q3 2019 | 11,944,000 | 16,142,000 |
| Q4 2019 | 2,035,000 | 230,000 |
| Q1 2020 | 12,098,000 | 13,743,000 |
| Q2 2020 | 11,559,000 | 29,112,000 |
| Q3 2020 | 15,304,000 | 8,951,000 |
| Q4 2020 | 17,621,000 | 20,568,000 |
| Q1 2021 | 10,978,000 | 10,001,000 |
| Q2 2021 | 20,628,000 | 21,330,000 |
| Q3 2021 | 24,168,000 | 24,258,000 |
| Q4 2021 | 15,829,000 | 3,765,000 |
| Q1 2022 | 3,562,000 | 1,808,000 |
| Q2 2022 | 11,347,000 | 13,532,000 |
| Q3 2022 | 4,012,000 | 5,079,000 |